Immune System

Thymalin

A natural thymus peptide complex that restores thymic function and immune competence - particularly studied for immune reconstitution in ageing and immunodeficiency.

Polypeptide complexHalf-life: ~30 minutesMolar mass: 1000.00 g/mol

Community Rating

No ratings yet

Compound Profile

Thymalin

Key Data

FormulaPolypeptide complex
Molar mass1000.0 g/mol
Half-life~30 minutes
CategoryImmune System

Research reference only

Research Focus

Restores thymic function and T-cell production in age-related thymic involution
Increases peripheral T-lymphocyte counts - CD4+ and CD8+ subsets in ageing and immunocompromised models
Enhances natural killer (NK) cell activity and cytokine production

Preclinical data

⚠ Research & Educational Use Only. Thymalin is a research chemical documented here for scientific education. All information references peer-reviewed literature and preclinical/clinical study data. Not for human consumption. Not medical advice. Consult a licensed researcher or healthcare professional before any laboratory use.

Chemistry review: Ashish KumarWritten by the KnowYourPeptide Research TeamLast updated July 2026
Our editorial standards →
Key Takeaways
  • Restores thymic function and T-cell production in age-related thymic involution
  • Increases peripheral T-lymphocyte counts - CD4+ and CD8+ subsets in ageing and immunocompromised models
  • Enhances natural killer (NK) cell activity and cytokine production
  • Thymalin is not FDA-approved for human use. It is a research chemical for scientific study only.

Research At a Glance

  • Restores thymic function and T-cell production in age-related thymic involution
  • Increases peripheral T-lymphocyte counts - CD4+ and CD8+ subsets in ageing and immunocompromised models
  • Enhances natural killer (NK) cell activity and cytokine production
  • Reduces cortisol-mediated immunosuppression in stress models
Calculate Thymalin dose
Who researches this:Researchers studying thymic peptide biology and age-related thymic involutionThose investigating Soviet-era immunostimulant compounds and their evidence basePeople interested in the Khavinson Institute's longevity research and the bioregulator peptide traditionScientists studying immune system restoration approaches in elderly populations
💡

In Plain English

Simple summary

Thymalin is a polypeptide extract from calf thymus gland developed by the St. Petersburg Institute of Bioregulation and Gerontology in the Soviet Union during the 1970s and 1980s. It's a complex mixture of thymic peptides (principally thymulin and related factors) rather than a single defined compound, which differentiates it from the Khavinson bioregulator peptides (like Thymagen, a defined dipeptide) developed from the same research program. Thymalin has a substantial Eastern European clinical literature behind it: a 2003 study by Vladimir Khavinson and colleagues followed elderly patients for 6-8 years and reported dramatically lower mortality rates in thymalin-treated groups. Western immunology researchers have viewed this literature with significant skepticism due to methodological questions.

  • Restores thymic function and T-cell production in age-related thymic involution
  • Increases peripheral T-lymphocyte counts - CD4+ and CD8+ subsets in ageing and immunocompromised models
  • Enhances natural killer (NK) cell activity and cytokine production

The full scientific detail, mechanisms, citations, and dosing data, follows below.

What is Thymalin?

Tap any underlined term for an instant definition.

Thymalin is a natural polypeptide complex isolated from the thymus gland of cattle, developed by the St. Petersburg Institute of Biogerontology in Russia during the 1970s-80s. It was part of a pioneering research program into the biological role of thymic peptides in immune regulation and ageing, led by Professor Vladimir Khavinson (who also developed Epithalon, Cortagen, and other bioregulators).

The thymus is the primary training ground for T-lymphocytes - the adaptive immune cells that orchestrate specific immune responses. The thymus is largest and most active in childhood and adolescence, then progressively involutes (shrinks and loses function) from puberty onwards. By age 40-50, thymic output has declined dramatically, contributing to the well-documented decline in immune competence with ageing (immunosenescence). This thymic involution is associated with reduced numbers and diversity of naive T-cells, impaired vaccine responses, increased susceptibility to infection, and potentially reduced immune surveillance against cancer.

Thymalin contains a mixture of small bioactive polypeptides that mimic the immunomodulatory signals normally produced by thymic epithelial cells. These signals normally direct the maturation, selection, and export of T-cells. By providing these signals exogenously, Thymalin aims to support or restore thymic function and peripheral T-cell .

The most compelling published data on Thymalin comes from a long-running Russian geriatric study. Elderly subjects (65-80 years old) treated with Thymalin twice-yearly for 8 years showed significantly reduced all-cause mortality compared to the control group, improved immune parameters, and better functional health outcomes. While methodological questions about this research remain (as with much Russian peptide bioregulator research), the clinical observations have sustained interest in thymic peptide biology as a longevity intervention.

Thymalin is closely related to but distinct from Thymosin Alpha-1 (Ta1, marketed as Zadaxin) - which is a single, defined 28-amino acid peptide. Thymalin is a more complex, less defined polypeptide mixture, more analogous to how a natural extract differs from a purified compound.

By the Numbers

1970s Soviet development
Developed alongside Epithalon and the full Khavinson bioregulator program -- part of a systematic effort to create organ-specific peptide treatments
6–8 year follow-up
The 2003 Khavinson study followed elderly patients for 6-8 years, reporting substantially lower mortality in thymalin-treated groups
Thymic extract
Complex mixture of thymic peptides rather than a single defined compound -- closer to organ extract therapy than modern defined-sequence peptides

Key Research Benefits

Documented effects observed in preclinical and clinical studies on Thymalin. See all Immune System peptides for comparison.

Restores thymic function and T-cell production in age-related thymic involution
Increases peripheral T-lymphocyte counts - CD4+ and CD8+ subsets in ageing and immunocompromised models
Enhances natural killer (NK) cell activity and cytokine production
Reduces cortisol-mediated immunosuppression in stress models
Improves vaccine response in elderly subjects - counteracts immunosenescence
Russian longevity research showed reduced all-cause mortality in elderly cohorts over 8 years of study
Normalises disturbed immunity in post-surgical and post-radiation recovery
Supports restoration of immune homeostasis in chronic inflammatory conditions

Common Stacks

Thymalin is frequently combined with the following peptides for synergistic effects. Click any peptide to compare profiles before deciding.

IGF-1 DES (short-acting, site-specific) and IGF-1 LR3 (long-acting, systemic) can be combined for both localised and systemic anabolic IGF-1 signalling.

IGF-1 LR3 profile

CJC-1295 drives endogenous GH/IGF-1 while IGF-1 DES provides direct, immediate post-workout receptor activation in target muscles.

CJC-1295 profile

Side Effects & Risks

Adverse effects reported in the research literature. All data sourced from preclinical and clinical study reports. View all peptides' side effects →

Dosing Data from the Literature

Doses referenced below are sourced from published preclinical and clinical studies. Use the peptide dose calculator to convert these values to injection volume.

Research Dosing Protocol

Thymalin research protocols from Russian longevity studies used 10 mg/day for 10 consecutive days, repeated twice yearly.

Standard research protocol: 10 mg IM or SC daily for 10 days Maintenance: repeat course twice per year Some protocols use 5 mg/day for 10 days for mild immunostimulation Monitor CBC and lymphocyte subsets to track immune

Enter your vial size and target dose to get the exact injection volume.

Administration in Research Settings

Standard reconstitution and administration methodology for laboratory research use.

Thymalin powder with physiological saline or . Administer intramuscularly or subcutaneously once daily for 10 consecutive days. The 10-day course is a standard Russian bioregulator protocol.

What the research doesn't show

The Khavinson mortality study has never been replicated by independent Western researchers, and the methodology has been questioned regarding randomization, blinding, and control group comparability. The Soviet/Russian bioregulator research tradition has produced genuinely interesting leads, but the publication record exists largely within a single institution's output and hasn't been subjected to the kind of rigorous independent replication that characterizes modern clinical evidence.

Medical Expert Videos

Physicians, researchers, and pharmacologists explain Thymalin, covering mechanisms of action, clinical context, and study findings.

YouTube, Thymalin · doctors & researchersOpen in YouTube

Videos sourced from YouTube search. KnowYourPeptide does not endorse any individual creator. For research education only.

📋

The Bottom Line

Thymalin has a growing body of preclinical evidence and a well-characterised safety profile in research settings. The most-studied application is: restores thymic function and t-cell production in age-related thymic involution.

The most commonly reported side effect in research subjects is mild injection site reactions. It is a research chemical, not approved for human use.

Research chemicalNot for human useEducational purposes only

Frequently Asked Questions

Explore Further

Quick Reference

Half-Life
~30 minutes
Molar Mass
1000.00 g/mol
Formula
Polypeptide complex
Legal Status
Approved pharmaceutical in Russia (Thymalin injection). Research chemical status in most Western countries.
Storage
Lyophilised: 2-8 degrees C, protect from light. Reconstituted: use within 24 hours.

How It Compares

Thymagen (Lys-Glu dipeptide) is a defined single peptide derived from the same thymalin research program. Thymosin alpha-1 (Zadaxin) is the most clinically developed thymic peptide globally and has regulatory approval in 35+ countries with better-defined mechanisms. Thymalin sits between organ extract therapy and modern defined peptides in terms of characterization.

Compare Thymalin side-by-side

Research Use Only

This information is for educational research purposes only. This is not medical advice. Consult a qualified healthcare professional.

AI Peptide Advisor

online · Claude + Gemini
ask your question...